Calidi Biotherapeutics, Inc. (CLDI)
R&D Expense Growth
9.68%
Fiscal year · Period ending:
CLDI R&D Expense Growth
Latest reported9.68%period ending
Latest reported9.68%period ending
CLDI FY R&D Growth (YoY) (0.00% → 9.68%)
Latest values, visible window
High-resolution chart · PNG
CLDI r&d expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| 9.6756% | |
| -31.7497% | |
| 79.2476% | |
| 55.2632% | |
| 46.8887% | |
| 0% |